Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 46 of 46 entries
View as:

Lifting and Tightening of the Face and Neck Following an Increased Density Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01519206 Org: User:
Start: 08/31/11 End: 03/31/13 Due: 03/31/14

Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck

Phase: N/A Priority: Normal
NCT ID: NCT01713985 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

Retrospective Evaluation of Combination Treatment With the Ulthera System

Phase: N/A Priority: Normal
NCT ID: NCT02444169 Org: User:
Start: 04/30/15 End: 07/31/15 Due: 07/31/16

Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne

Phase: N/A Priority: Normal
NCT ID: NCT01591304 Org: User:
Start: 08/31/11 End: 07/31/14 Due: 07/31/15

Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue

Phase: N/A Priority: Normal
NCT ID: NCT01708499 Org: User:
Start: 03/31/12 End: 04/30/13 Due: 04/30/14

Ulthera® System for Treating Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT02286765 Org: User:
Start: 10/31/14 End: 09/30/16 Due: 09/30/17

Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers

Phase: N/A Priority: Normal
NCT ID: NCT02416076 Org: User:
Start: 12/15/14 End: 01/31/16 Due: 01/31/17

Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT03320096 Org: User:
Start: 12/13/16 End: 08/22/17 Due: 08/22/18

Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01708252 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

Gene Expression Following Ultherapy® Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02441036 Org: User:
Start: 05/01/15 End: 08/18/16 Due: 08/18/17

Evaluation of the Ulthera® System for Treatment of the Brachia

Phase: N/A Priority: Normal
NCT ID: NCT01713933 Org: User:
Start: 06/30/11 End: 05/31/12 Due: 05/31/13

Ultherapy™ Treatment Following Sculptra® Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01422538 Org: User:
Start: 05/31/11 End: 09/30/12 Due: 09/30/13

Histological Analysis Following Ulthera System Treatment for Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT01708551 Org: User:
Start: 08/31/12 End: 08/31/15 Due: 08/31/16

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Phase: N/A Priority: Normal
NCT ID: NCT01981252 Org: User:
Start: 10/31/13 End: 08/31/14 Due: 08/31/15

Ultherapy for the Treatment of Spider Veins on the Legs

Phase: N/A Priority: Normal
NCT ID: NCT02286804 Org: User:
Start: 10/31/14 End: 05/31/15 Due: 05/31/16

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

Phase: N/A Priority: Normal
NCT ID: NCT01519934 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Feasibility Study: Ulthera System for the Treatment of Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01756027 Org: User:
Start: 11/30/12 End: 10/31/13 Due: 10/31/14

Feasibility Study: Heavy Water Tissue Labeling Protocol

Phase: N/A Priority: Normal
NCT ID: NCT01708525 Org: User:
Start: 08/31/12 End: 11/30/13 Due: 11/30/14

Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck

Phase: N/A Priority: Normal
NCT ID: NCT01708512 Org: User:
Start: 04/30/12 End: 07/31/13 Due: 07/31/14

Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT01713673 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

Feasibility Study: Lifting and Tightening of the Elbows

Phase: N/A Priority: Normal
NCT ID: NCT01708382 Org: User:
Start: 09/30/11 End: 02/28/13 Due: 02/28/14